List of Tables
Table 1. Global Pulmonary Administration Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pulmonary Administration Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pulmonary Administration Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pulmonary Administration Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pulmonary Administration Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pulmonary Administration Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Pulmonary Administration Sales by Region (2020-2025) & (K Units)
Table 8. Global Pulmonary Administration Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pulmonary Administration Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Pulmonary Administration Sales Share by Manufacturers (2020-2025)
Table 12. Global Pulmonary Administration Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Pulmonary Administration Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Pulmonary Administration by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Administration as of 2024)
Table 16. Global Pulmonary Administration Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Pulmonary Administration Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Pulmonary Administration Manufacturing Base and Headquarters
Table 19. Global Pulmonary Administration Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Pulmonary Administration Sales by Type (2020-2025) & (K Units)
Table 23. Global Pulmonary Administration Sales by Type (2026-2031) & (K Units)
Table 24. Global Pulmonary Administration Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Pulmonary Administration Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Pulmonary Administration ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Pulmonary Administration Sales by Application (2020-2025) & (K Units)
Table 29. Global Pulmonary Administration Sales by Application (2026-2031) & (K Units)
Table 30. Pulmonary Administration High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Pulmonary Administration Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Pulmonary Administration Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Pulmonary Administration ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Pulmonary Administration Growth Accelerators and Market Barriers
Table 37. North America Pulmonary Administration Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Pulmonary Administration Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Pulmonary Administration Growth Accelerators and Market Barriers
Table 40. Europe Pulmonary Administration Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Pulmonary Administration Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Pulmonary Administration Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Pulmonary Administration Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Pulmonary Administration Growth Accelerators and Market Barriers
Table 45. Southeast Asia Pulmonary Administration Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Pulmonary Administration Investment Opportunities and Key Challenges
Table 47. Central and South America Pulmonary Administration Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Pulmonary Administration Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Pulmonary Administration Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Aptar Pharma Corporation Information
Table 51. Aptar Pharma Description and Major Businesses
Table 52. Aptar Pharma Product Models, Descriptions and Specifications
Table 53. Aptar Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Aptar Pharma Sales Value Proportion by Product in 2024
Table 55. Aptar Pharma Sales Value Proportion by Application in 2024
Table 56. Aptar Pharma Sales Value Proportion by Geographic Area in 2024
Table 57. Aptar Pharma Pulmonary Administration SWOT Analysis
Table 58. Aptar Pharma Recent Developments
Table 59. Nemera Corporation Information
Table 60. Nemera Description and Major Businesses
Table 61. Nemera Product Models, Descriptions and Specifications
Table 62. Nemera Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Nemera Sales Value Proportion by Product in 2024
Table 64. Nemera Sales Value Proportion by Application in 2024
Table 65. Nemera Sales Value Proportion by Geographic Area in 2024
Table 66. Nemera Pulmonary Administration SWOT Analysis
Table 67. Nemera Recent Developments
Table 68. Porex Corporation Information
Table 69. Porex Description and Major Businesses
Table 70. Porex Product Models, Descriptions and Specifications
Table 71. Porex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Porex Sales Value Proportion by Product in 2024
Table 73. Porex Sales Value Proportion by Application in 2024
Table 74. Porex Sales Value Proportion by Geographic Area in 2024
Table 75. Porex Pulmonary Administration SWOT Analysis
Table 76. Porex Recent Developments
Table 77. Chiesi Farmaceutici Corporation Information
Table 78. Chiesi Farmaceutici Description and Major Businesses
Table 79. Chiesi Farmaceutici Product Models, Descriptions and Specifications
Table 80. Chiesi Farmaceutici Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Chiesi Farmaceutici Sales Value Proportion by Product in 2024
Table 82. Chiesi Farmaceutici Sales Value Proportion by Application in 2024
Table 83. Chiesi Farmaceutici Sales Value Proportion by Geographic Area in 2024
Table 84. Chiesi Farmaceutici Pulmonary Administration SWOT Analysis
Table 85. Chiesi Farmaceutici Recent Developments
Table 86. AstraZeneca Corporation Information
Table 87. AstraZeneca Description and Major Businesses
Table 88. AstraZeneca Product Models, Descriptions and Specifications
Table 89. AstraZeneca Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AstraZeneca Sales Value Proportion by Product in 2024
Table 91. AstraZeneca Sales Value Proportion by Application in 2024
Table 92. AstraZeneca Sales Value Proportion by Geographic Area in 2024
Table 93. AstraZeneca Pulmonary Administration SWOT Analysis
Table 94. AstraZeneca Recent Developments
Table 95. H&T Presspart Corporation Information
Table 96. H&T Presspart Description and Major Businesses
Table 97. H&T Presspart Product Models, Descriptions and Specifications
Table 98. H&T Presspart Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. H&T Presspart Recent Developments
Table 100. Gerresheimer Corporation Information
Table 101. Gerresheimer Description and Major Businesses
Table 102. Gerresheimer Product Models, Descriptions and Specifications
Table 103. Gerresheimer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Gerresheimer Recent Developments
Table 105. Merxin Ltd Corporation Information
Table 106. Merxin Ltd Description and Major Businesses
Table 107. Merxin Ltd Product Models, Descriptions and Specifications
Table 108. Merxin Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Merxin Ltd Recent Developments
Table 110. 3M Corporation Information
Table 111. 3M Description and Major Businesses
Table 112. 3M Product Models, Descriptions and Specifications
Table 113. 3M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. 3M Recent Developments
Table 115. Aerogen Pharma Corporation Information
Table 116. Aerogen Pharma Description and Major Businesses
Table 117. Aerogen Pharma Product Models, Descriptions and Specifications
Table 118. Aerogen Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Aerogen Pharma Recent Developments
Table 120. MedPharm Corporation Information
Table 121. MedPharm Description and Major Businesses
Table 122. MedPharm Product Models, Descriptions and Specifications
Table 123. MedPharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. MedPharm Recent Developments
Table 125. Kindeva Drug Delivery Corporation Information
Table 126. Kindeva Drug Delivery Description and Major Businesses
Table 127. Kindeva Drug Delivery Product Models, Descriptions and Specifications
Table 128. Kindeva Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Kindeva Drug Delivery Recent Developments
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Major Businesses
Table 132. Boehringer Ingelheim Product Models, Descriptions and Specifications
Table 133. Boehringer Ingelheim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Boehringer Ingelheim Recent Developments
Table 135. Chiesi Farmaceutici SpA Corporation Information
Table 136. Chiesi Farmaceutici SpA Description and Major Businesses
Table 137. Chiesi Farmaceutici SpA Product Models, Descriptions and Specifications
Table 138. Chiesi Farmaceutici SpA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Chiesi Farmaceutici SpA Recent Developments
Table 140. Merck & Co, Inc Corporation Information
Table 141. Merck & Co, Inc Description and Major Businesses
Table 142. Merck & Co, Inc Product Models, Descriptions and Specifications
Table 143. Merck & Co, Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Merck & Co, Inc Recent Developments
Table 145. Novartis AG Corporation Information
Table 146. Novartis AG Description and Major Businesses
Table 147. Novartis AG Product Models, Descriptions and Specifications
Table 148. Novartis AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Novartis AG Recent Developments
Table 150. PARI international Corporation Information
Table 151. PARI international Description and Major Businesses
Table 152. PARI international Product Models, Descriptions and Specifications
Table 153. PARI international Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. PARI international Recent Developments
Table 155. Vectura Group Plc Corporation Information
Table 156. Vectura Group Plc Description and Major Businesses
Table 157. Vectura Group Plc Product Models, Descriptions and Specifications
Table 158. Vectura Group Plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Vectura Group Plc Recent Developments
Table 160. GlaxoSmithKline Corporation Information
Table 161. GlaxoSmithKline Description and Major Businesses
Table 162. GlaxoSmithKline Product Models, Descriptions and Specifications
Table 163. GlaxoSmithKline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. GlaxoSmithKline Recent Developments
Table 165. Koninklijke Philips NV Corporation Information
Table 166. Koninklijke Philips NV Description and Major Businesses
Table 167. Koninklijke Philips NV Product Models, Descriptions and Specifications
Table 168. Koninklijke Philips NV Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Koninklijke Philips NV Recent Developments
Table 170. OMRON Corporation Corporation Information
Table 171. OMRON Corporation Description and Major Businesses
Table 172. OMRON Corporation Product Models, Descriptions and Specifications
Table 173. OMRON Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. OMRON Corporation Recent Developments
Table 175. Sunovion Pharmaceuticals, Inc Corporation Information
Table 176. Sunovion Pharmaceuticals, Inc Description and Major Businesses
Table 177. Sunovion Pharmaceuticals, Inc Product Models, Descriptions and Specifications
Table 178. Sunovion Pharmaceuticals, Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. Sunovion Pharmaceuticals, Inc Recent Developments
Table 180. Teva Pharmaceutical Industries Ltd Corporation Information
Table 181. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 182. Teva Pharmaceutical Industries Ltd Product Models, Descriptions and Specifications
Table 183. Teva Pharmaceutical Industries Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 184. Teva Pharmaceutical Industries Ltd Recent Developments
Table 185. Yisuo Intelligent Corporation Information
Table 186. Yisuo Intelligent Description and Major Businesses
Table 187. Yisuo Intelligent Product Models, Descriptions and Specifications
Table 188. Yisuo Intelligent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 189. Yisuo Intelligent Recent Developments
Table 190. Key Raw Materials Distribution
Table 191. Raw Materials Key Suppliers
Table 192. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 193. Milestones in Production Technology Evolution
Table 194. Distributors List
Table 195. Market Trends and Market Evolution
Table 196. Market Drivers and Opportunities
Table 197. Market Challenges, Risks, and Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Administration Product Picture
Figure 2. Global Pulmonary Administration Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pressurized Metered Dose Inhalation System Product Picture
Figure 4. Dry Powder Inhalation System Product Picture
Figure 5. Soft Mist Inhalation System Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pulmonary Administration Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Bronchial Asthma
Figure 9. Chronic Obstructive Pulmonary Disease
Figure 10. Others
Figure 11. Pulmonary Administration Report Years Considered
Figure 12. Global Pulmonary Administration Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 14. Global Pulmonary Administration Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Pulmonary Administration Revenue Market Share by Region (2020-2031)
Figure 16. Global Pulmonary Administration Sales (2020-2031) & (K Units)
Figure 17. Global Pulmonary Administration Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Pulmonary Administration Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Pulmonary Administration Sales Volume Market Share in 2024
Figure 20. Global Pulmonary Administration Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Pressurized Metered Dose Inhalation System Revenue Market Share by Manufacturer in 2024
Figure 23. Dry Powder Inhalation System Revenue Market Share by Manufacturer in 2024
Figure 24. Soft Mist Inhalation System Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global Pulmonary Administration Sales Market Share by Type (2020-2031)
Figure 27. Global Pulmonary Administration Revenue Market Share by Type (2020-2031)
Figure 28. Global Pulmonary Administration Sales Market Share by Application (2020-2031)
Figure 29. Global Pulmonary Administration Revenue Market Share by Application (2020-2031)
Figure 30. North America Pulmonary Administration Sales YoY (2020-2031) & (K Units)
Figure 31. North America Pulmonary Administration Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Pulmonary Administration Sales Revenue (US$ Million) in 2024
Figure 33. North America Pulmonary Administration Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Pulmonary Administration Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Pulmonary Administration Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Pulmonary Administration Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Pulmonary Administration Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Pulmonary Administration Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Pulmonary Administration Sales Revenue (US$ Million) in 2024
Figure 43. Europe Pulmonary Administration Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Pulmonary Administration Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Pulmonary Administration Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Pulmonary Administration Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 48. France Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Pulmonary Administration Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Pulmonary Administration Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Pulmonary Administration Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Pulmonary Administration Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Pulmonary Administration Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Pulmonary Administration Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Pulmonary Administration Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 63. India Pulmonary Administration Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Pulmonary Administration Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Pulmonary Administration Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Pulmonary Administration Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Pulmonary Administration Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Pulmonary Administration Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Pulmonary Administration Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Pulmonary Administration Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Pulmonary Administration Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Pulmonary Administration Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Pulmonary Administration Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Pulmonary Administration Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Pulmonary Administration Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Pulmonary Administration Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Pulmonary Administration Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Pulmonary Administration Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Pulmonary Administration Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Pulmonary Administration Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Pulmonary Administration Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Pulmonary Administration Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Pulmonary Administration Revenue (2020-2025) & (US$ Million)
Figure 84. Pulmonary Administration Industry Chain Mapping
Figure 85. Regional Pulmonary Administration Manufacturing Base Distribution (%)
Figure 86. Global Pulmonary Administration Production Market Share by Region (2020-2031)
Figure 87. Pulmonary Administration Production Process
Figure 88. Regional Pulmonary Administration Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
